Vildagliptin (Galvus)

DRUG3 trials

Sponsors

University Hospital, Strasbourg, France, Fundación para la Investigación del Hospital Clínico de Valencia, Tanta University

Conditions

Diabetes Mellitus Type 2Haemodialyzed, Type 2 DiabetesPoly Cystic Ovary Syndrome

Phase 2

Efficacy of Dapagliflozin Versus Metformin in Patients With Polycystic Ovary Syndrome

Not yet recruitingNCT07811011

Tanta UniversityPoly Cystic Ovary Syndrome

Start: 2026-09-20End: 2027-03-30Target: 70Updated: 2026-09-09

Phase 4

A Prospective, Multicenter, Randomized, Open-label Study of 12 Week Duration to Evaluate the Effect of VILDagliptin Added to Insulin on Glycaemic Control in haemoDIALyzed Patients With Type 2 Diabetes: Probe Analysis of CGM

CompletedNCT02176681

University Hospital, Strasbourg, FranceHaemodialyzed, Type 2 Diabetes

Start: 2014-06-01End: 2017-10-01Updated: 2026-03-16

Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.

CompletedNCT06851962

Fundación para la Investigación del Hospital Clínico de ValenciaDiabetes Mellitus Type 2

Start: 2025-05-26End: 2026-06-30Updated: 2026-09-04